Insiders Sanofi BOERSE MUENCHEN

Equities

Market Closed - BOERSE MUENCHEN Other stock markets 01:13:40 29/06/2024 am IST			5-day change	1st Jan Change
89.98 ^EUR	+0.57%		+2.27%	+0.21%

27/06	CAC40: caution prevails ahead of crucial deadlines	CF
27/06	CAC40: consolidates solo, OAT/Bund spread widens to 81Pb	CF

Sanofi: new Director of Group Corporate Affairs	21/06	CF
Sanofi Appoints Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs and Member of its Executive Committee, Effective July 1, 2024	21/06	CI
Jasper Therapeutics, Inc. Announces Board Changes	19/06	CI
Ipsen Hires New Chief Corporate Affairs Officer	06/06	MT
CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer	23/05	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	11/05	MT
Sanofi Announces Board and Committee Appointments	30/04	CI
Smith & Nephew CFO designate John Rogers to start next week	28/03	AN
Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell	25/03	MT
Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%	29/02	MT
Sanofi appoints Smith & Nephew CFO Nesmes to board	23/02	AN
Sanofi Proposes Appointment of New Independent Directors	23/02	DJ
Sanofi: three nominations for the Board of Directors	23/02	CF
Sanofi Announces Board Resignations	23/02	CI
Sanofi's Q4 Non-GAAP Earnings Fall While Net Sales Rise; Names Francois-Xavier Roger CFO	01/02	MT
Sanofi: new CFO in early April	01/02	CF
Sanofi Appoints Nestlé CFO to Same Role	01/02	MT
Sanofi Announces Executive Changes, Effective April 1, 2024	01/02	CI
Sanofi confirms it expects a decline in business EPS in 2024	01/02	RE
Sanofi Appoints Brian Foard as Head of Specialty Care Global Business Unit and Member of Executive Committee	09/01	CI